1. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50(2):140-148.
  2. Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE. "Minimal change" multiple system atrophy. Mov Disord 1994;9(2):161-166.
  3. Stadlan EM, Yahr MD. The pathology of parkinsonism. Proceedings of the 5th International Congress of Neuropathology 1965;100:569-571.
  4. Winogrodzka A, Wagenaar RC, Bergmans P, et al. Rigidity decreases resting tremor intensity in Parkinson's disease: a (123)beta-CIT SPECT study in early, non-medicated patients. Mov Disord 2001;16:1033-1040.
  5. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord 2003;18(4):364-372.
  6. Steele J, Richardson J, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
  7. Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118(Pt 3):759-770.
  8. Morris HR, Gibb G, Katzenschlager R, et al. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 2002;125(Pt 5):969-975.
  9. Gibb WR, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987;110(Pt 5):1131-1153.
  10. Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000;55(4):539-544.
  11. Burn DJ, Rowan EN, Minett T, et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord 2003;18(8):884-889.
  12. Chaudhuri KR, Hu MT, Brooks DJ. Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK. Mov Disord 2000;15(1):18-23.
  13. Schrag A, Bhatt M, Soonawala N, Quinn NP, Bhatia KP. Occurrence of atypical parkinsonism in Indians and Caucasians. Acta Neurol Scand 2004;109(2):155-156.
  14. Hu M. Cortical and Striatal Function in a Cross-Racial Parkinson's Disease Population. London: Guys, Kings and St. Thomas's School of Medicine, 2000. PhD thesis, University of London.
  15. Hirano A, Kurland L, Krooth R, Lessell S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. 1. Clinical Features. Brain 1961;84:642-661.
  16. Caparros-Lefebvre D, Elbaz A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet 1999;354(9175):281-286.
  17. Caparros-Lefebvre D, Sergeant N, Lees A, et al. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 2002;125(Pt 4):801-811.
  18. Subramony SH, Hernandez D, Adam A, et al. Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians. Mov Disord 2002;17(5):1068-1071.
  19. Furtado S, Farrer M, Tsuboi Y, et al. SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology 2002;59(10):1625-1627.
  20. Payami H, Nutt J, Gancher S, et al. SCA2 may present as levodopa-responsive parkinsonism. Mov Disord 2003;18(4):425-429.
  21. Reuter I, Hu MT, Andrews TC, Brooks DJ, Clough C, Chaudhuri KR. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000;68(2):238-241.
  22. Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 1988;51(6):850-854.
  23. Tolosa E, Coelho M, Gallardo M. DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord 2003;18(Suppl 7):S28-S33.
  24. Tolosa ES, Santamaria J. Parkinsonism and basal ganglia infarcts. Neurology 1984;34(11):1516-1518.
  25. Ziljmans J, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinico-Pathological Investigation of Vascular Parkinsonism(VP) Including Clinical Criteria for the Diagnosis of VP. Mov Disord, published online, March 16, 2004.
  26. Katzenschlager R, Cardoso A, Tolosa E, Lees A. Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Mov Disord 2003;18:1123-1131.
  27. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55(3):181-184.
  28. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57(8):1497-1499.
  29. Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Accuracy of Clinical Diagnosis of Progressive Supranuclear Palsy. Mov Disord 2004;19:181-189.
  30. Osaki Y, Wenning GK, Daniel SE, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002;59(10):1486-1491.
  31. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58(2):160-166.
  32. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54(8):937-944.
  33. Colosimo C, Albanese A, Hughes AJ, de Bruin VM, and Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52(3):294-298.
  34. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125(Pt 4):861-870.

Was this article helpful?

0 0

Post a comment